Order results by:
Issue | Title | |
Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
"... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..." | ||
Vol 11, No 5 (2015) | Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis | Abstract similar documents |
N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov | ||
"... -cholesterol) were significantly higher among patients not taking lipid-lowering therapy. 62.1% of patients ..." | ||
Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
"... Aim. To assess the quality of lipid-lowering therapy in high risk patients with cardiovascular ..." | ||
Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
"... strategy in increasing the frequency of low-density lipoprotein cholesterol (LDL-С) monitoring in patients ..." | ||
Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
"... lipid-lowering agents were used only in rare cases. From 2011 to 2015 the proportion of patients taking ..." | ||
Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
"... Aim. To assess the economic burden associated with the absence of lipid-lowering therapy (LLT ..." | ||
Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
"... cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention ..." | ||
Vol 14, No 6 (2018) | The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial | Abstract PDF (Eng) similar documents |
Yu. A. Karpov | ||
"... of patients with low-density lipoprotein cholesterol ≥2,6 mmol/l at baseline. These results have implication ..." | ||
Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
I. V. Sergienko, A. A. Ansheles | ||
"... treated with lipid-lowering drugs. Patients with lipid-lowering therapy had significantly higher values ..." | ||
Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
V. A. Sergeeva | ||
"... in 2014) who were treated in the cardiology clinic were examined. Patient survey on the lipid-lowering ..." | ||
Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
"... .3% and a specificity of 90%. Conclusion. Intensive lipid-lowering therapy in patients with a very high cardiovascular ..." | ||
Vol 6, No 1 (2010) | EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS | Abstract PDF (Eng) similar documents |
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova | ||
"... in patients with IHD after cardiovascular events. Lipid-lowering therapy is conducted inefficiently ..." | ||
Vol 19, No 6 (2023) | New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist | Abstract similar documents |
A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova | ||
"... of combination lipid-lowering therapy for secondary prevention in patients at very high cardiovascular risk ..." | ||
Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
M. V. Solodun, S. S. Yakushin | ||
"... . All patients were prescribed atorvastatin. A group of 65 people in whom lipid levels were studied ..." | ||
Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
"... ; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination ..." | ||
Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..." | ||
Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
"... ) and require enhanced lipid-lowering therapy. Material and methods. The study included 49 patients (aged of 61 ..." | ||
Vol 20, No 4 (2024) | Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis | Abstract similar documents |
S. S. Vedenskaya, O. G. Smolenskaya | ||
"... received antihypertensive, lipid-lowering, and antiplatelet therapy. Results. Patients in groups 1 and 2 ..." | ||
Vol 17, No 6 (2021) | Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident | Abstract similar documents |
S. A. Boytsov, M. A. Piradov, M. M. Tanashyan, I. A. Voznjouk, M. V. Ezhov, E. V. Oschepkova, I. V. Sergienko, N. A. Shamalov, S. N. Yanishevskiy | ||
"... of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy ..." | ||
Vol 10, No 5 (2014) | EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION | Abstract similar documents |
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova | ||
"... cholesterol target levels by the end of the third month of treatment in 91% of patients. Elevated liver ..." | ||
Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
"... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..." | ||
Vol 17, No 2 (2021) | Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care | Abstract PDF (Eng) similar documents |
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova | ||
"... .0 and 87.8%; p>0.05). Adherent patients had lower mean values of lipids: total cholesterol (4.7±1.2 vs 5 ..." | ||
Vol 10, No 5 (2014) | RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME | Abstract similar documents |
N. V. Perova, V. A. Metelskaya | ||
"... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..." | ||
Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
"... for the effectiveness of 3-month lipid-lowering therapy was a decrease in LDL-C level by 1 mmol/l. The median ..." | ||
Vol 2, No 3 (2006) | EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova | ||
"... . Mildronate did not have any effect on the blood lipid profile in elderly patients with IHD. The initial level ..." | ||
Vol 17, No 1 (2021) | Lipid Clinic is an Efficacious Model of Preventive Medicine | Abstract PDF (Eng) similar documents |
A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina | ||
"... lipid clinic more often (61.5%). 48.5% of patients had low density lipoprotein cholesterol (LDL-c) >4 ..." | ||
Vol 19, No 2 (2023) | Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) | Abstract similar documents |
M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov | ||
"... Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy ..." | ||
Vol 17, No 6 (2021) | PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center | Abstract similar documents |
A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina | ||
"... records of patients who visited the Lipid clinic of the National Medical Research Center for Therapy ..." | ||
Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
"... ) in young patients. Material and methods. The study design is based on a comparison of observation data ..." | ||
Vol 13, No 1 (2017) | VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE | Abstract similar documents |
V. А. Korneva, T. Yu. Kuznetsova, G. P. Tihova | ||
"... in the Republic of Karelia. Material and methods. Parameters of lipid spectrum of 219 patients (aged 52.5±1 ..." | ||
Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
"... The high prevalence of lipid metabolism disorders in the Russian population and their contribution ..." | ||
Vol 5, No 5 (2009) | ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS | Abstract similar documents |
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina | ||
"... Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus ..." | ||
Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
"... cholesterol (LDL-C) as the primary target in addressing lipid-lowering therapy. The target level of LDL-C ..." | ||
Vol 16, No 1 (2020) | Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease | Abstract PDF (Eng) similar documents |
O. A. Koshelskaya, T. E. Suslova, I. V. Kologrivova, N. Y. Margolis, O. A. Zhuravleva, O. A. Kharitonova, I. V. Vinnitskaya | ||
"... angiography was performed in all patients. Basic serum parameters of carbohydrate and lipid metabolism were ..." | ||
Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
"... <0.05) were observed. A number of patients with achieved target levels of all studied lipid ..." | ||
Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
"... Aim. To study the dynamics of the lipid profile of hypertensive patients with dyslipidemia who ..." | ||
Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
"... for achieving lower concentrations of lowdensity lipoprotein cholesterol in patients with high and very high ..." | ||
Vol 17, No 5 (2021) | A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases | Abstract PDF (Eng) similar documents |
Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva | ||
"... therapy in patients with high or very high risk of cardiovascular complications. Material and methods ..." | ||
Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
A. N. Meshkov | ||
"... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..." | ||
Vol 13, No 5 (2017) | AGE AND GENDER PECULIARITIES OF BLOOD LIPIDS IN URBAN RESIDENTS (CROSS-SECTIONAL STUDY RESULTS) | Abstract similar documents |
S. A. Urazgildeeva, M. Yu. Nizhegorodcev, P. S. Sadovnikov, A. Yu. Olkhovik, D. Yu. Nokhrin, M. V. Muzalevskaya, I. V. Shugurova, D. G. Malenkovskaya, A. V. Tregubov, V. S. Gurevich | ||
"... Aim. To analyze the results of measurements of the blood lipid spectrum of urban residents ..." | ||
Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
"... that metabolic correctors exert positive influence on lipid profile and inflammatory factors in patients with IHD. ..." | ||
Vol 11, No 2 (2015) | HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER | Abstract similar documents |
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
"... be taken into consideration). 67% of patients had good adherence to lipid-lowering therapy 3.9 years after ..." | ||
Vol 9, No 5 (2013) | ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) | Abstract PDF (Eng) similar documents |
Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels | ||
"... the importance of lowering drug costs. 11 patients of 272 respondents demanded more care from their doctor; 4 ..." | ||
Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
O. M. Drapkina, A. S. Lishuta | ||
"... measurements, lipid levels were taken from the patient's medical records. The safety assessment was also ..." | ||
Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
"... Aim. To study the level of total cholesterol in patients at high and very high cardiovascular risk ..." | ||
Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
"... . Examination of patients with STEMI included the assessment of plasma lipid profile, blood levels of hepatic ..." | ||
Vol 11, No 1 (2015) | HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE | Abstract similar documents |
S. V. Shalaev, L. V. Silicic, O. V. Abaturova | ||
"... Aspects of heart rate-lowering therapy in patients with chronic heart failure using If-channel ..." | ||
Vol 18, No 3 (2022) | Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study | Abstract similar documents |
E. D. Zharkova, S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, O. M. Drapkina | ||
"... .002), lipid-lowering drugs (p=0.008) by patients was found during the second visit. The proportion of patients ..." | ||
Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
"... prescribed antihypertensive and lipid-lowering therapy, recommendations for a healthy lifestyle. In the main ..." | ||
Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
"... with hyperlipidemia. Material and methods. Patients (6 men and 24 women) aged 38 to 77 years, which needed in lipid ..." | ||
Vol 16, No 1 (2020) | The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion) | Abstract similar documents |
M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva | ||
"... with the prospect of lifelong therapy with lipid-lowering drugs. These individuals do not have an indication ..." | ||
Vol 17, No 3 (2021) | Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension | Abstract similar documents |
E. V. Kokhan, G. K. Kiyakbaev, E. M. Ozova, V. A. Romanova, Zh. D. Kobalava | ||
"... ) function in hypertensive patients with paroxysmal or persistent mild symptomatic atrial fibrillation ..." | ||
Vol 4, No 2 (2008) | EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY | Abstract similar documents |
A. V. Semenov, D. A. Sichev, V. G. Kukes | ||
"... of lipid-lowering diet. Atorvastatin (80 mg once daily in the first treatment day) was given to patients ..." | ||
Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
"... ) in stable ischemic heart disease patients. Material and methods. 264 patients (213 male, age 58.8±1.0 years ..." | ||
Vol 21, No 2 (2025) | Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention | Abstract similar documents |
M. А. Meshkova, I. A. Starodubtseva, A. A. Pashkova | ||
"... as the achievement of target low-density lipoprotein cholesterol level with lipid-lowering therapy. Material ..." | ||
Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
"... to the clinical guidelines) of the low density cholesterol (LDC) had been reached in 26.3% of patients in the main ..." | ||
Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
"... This article affects the problems of using NOAC in the most defenseless groups of patients ..." | ||
Vol 13, No 3 (2017) | TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 | Abstract similar documents |
O. M. Drapkina, A. S. Luishuta | ||
"... ) measurements, and lipid blood levels were taken from the patient's medical records. Results. 1736 patients (53 ..." | ||
Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
"... prescribed to elderly patients. Review of clinical and pharmacoepidemiological studies allows us to conclude ..." | ||
Vol 13, No 2 (2017) | TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 | Abstract similar documents |
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko | ||
"... Aim. Assessment of compliance the management of elderly patients (≥75 years) with acute coronary ..." | ||
Vol 6, No 4 (2010) | EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA | Abstract similar documents |
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev | ||
"... and high level of lipid peroxygenation (LPO). At the second step two groups of patients (n=28 and 31 ..." | ||
Vol 20, No 5 (2024) | Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now | Abstract PDF (Eng) similar documents |
S. A. Shalnova, A. E Imaeva, Yu. A Balanova, V. A Kutsenko, A. V Kapustina, V. A Metelskaya, N. A Imaeva, B. M Nazarov, O. E Ivlev, E. B Yarovaya, O. M Drapkina | ||
"... cardiovascular disease (CVD) who did not receive lipid-lowering therapy, participants of two independent ..." | ||
Vol 18, No 4 (2022) | Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders | Abstract PDF (Eng) similar documents |
S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina | ||
"... Aim. To perform a population analysis of Non-High Density Lipoprotein Cholesterol level (non-HDL-c ..." | ||
Vol 3, No 1 (2007) | COMPARATIVE ANALYSIS OF SATISFACTION IN HOSPITAL TREATMENT AMONG CARDIOLOGICAL PATIENTS | Abstract similar documents |
Y. G. Shvarts, E. A. Naumova, E. V. Tarasenko | ||
"... Aim. To evaluate satisfaction in hospital treatment among cardiological patients and to compare ..." | ||
Vol 14, No 2 (2018) | WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY | Abstract similar documents |
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin | ||
"... Aim. To study the awareness and opinion of patients with atrial fibrillation (AF) about the stroke ..." | ||
Vol 14, No 4 (2018) | Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice | Abstract similar documents |
N. M. Vorobyeva, O. N. kacheva | ||
"... The possibility of rivaroxaban using in elderly patients with non-valvular atrial fibrillation ..." | ||
Vol 21, No 1 (2025) | Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment | Abstract similar documents |
A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov | ||
"... (FH) diagnosis. Material and methods. A retrospective cohort study included 45 patients (25 men ..." | ||
Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
"... . Results. Controlled lipid-lowering therapy in combination with UDCA resulted in a significant reduction ..." | ||
Vol 6, No 1 (2010) | PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya | ||
"... Aim. To study purine metabolism and lipid peroxidation in patients with acute myocardial ..." | ||
Vol 6, No 4 (2010) | EFFECTS OF ACUTE PHYSICAL EXERCISE OF VARYING INTENSITY ON LIPID METABOLISM IN MIDDLE AGED MEN | Abstract similar documents |
G. E. Roytberg, I. D. Slastnikova, O. Ju. Dmitrieva, T. I. Ushakova | ||
"... of lipid profile (total cholesterol, high density lipoprotein cholesterol, triglyceride levels ..." | ||
Vol 17, No 1 (2021) | Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council | Abstract similar documents |
M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, N. M. Akhmedzhanov, M. I. Voevoda, V. S. Gurevich, V. V. Kashtalap, V. O. Konstantinov, V. V. Skibitsky, I. I. Shaposhnik | ||
"... of the strategy of early combined lipid-lowering therapy for doctors and these categories of patients was held ..." | ||
Vol 12, No 4 (2016) | Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs | Abstract similar documents |
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
"... and falls in the “very elderly” patients. Available data suggest that elderly patients do not have ..." | ||
Vol 12, No 5 (2016) | Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs | Abstract similar documents |
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
"... The effectiveness of antiarrhythmic drugs in the elderly is similar to that in younger patients ..." | ||
Vol 7, No 3 (2011) | REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 | Abstract similar documents |
N. V. Perova | ||
"... (LDL) cholesterol was determined in three large meta-analysis. Besides, it was found that standardized ..." | ||
Vol 17, No 2 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options | Abstract similar documents |
V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
"... in patients with multifocal arterial lesions using antihypertensive, antithrombotic and lipid-lowering therapy ..." | ||
Vol 20, No 2 (2024) | The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age | Abstract similar documents |
S. A. Shalnova, E. B. Yarovaya, V. A. Metelskaya, E. M. Filichkina, A. V. Kapustina, V. A. Kutsenko, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, S. E. Evstifeeva, S. A. Maksimov, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, Yu. I. Grinshtein, R. A. Libis, O. P Rotar, I. A. Trubacheva, A. Yu. Efanov, S. S. Yakushin, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, A. O. Konradi, S. A. Boytsov, E. V Shlyakhto, O. M. Drapkina | ||
"... cholesterol (LDL-C) level and their combination to the development of (myocardial infarction) MI and stroke ..." | ||
Vol 3, No 1 (2007) | EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova | ||
"... Aim. To study clinical efficacy of a new domestic metabolic drug Eltacine in patients with chronic ..." | ||
Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
"... lipoprotein (LDL) cholesterol level. Material and methods. Patients aged 33-85 years with angiography ..." | ||
Vol 16, No 1 (2020) | Cross-Sectional Study to Estimate the Prevalence of Familial Hypercholesterolemia in Selected Regions of the Russian Federation: Relevance, Design of the Study and Initial Characteristics of the Participants | Abstract similar documents |
A. N. Meshkov, A. I. Ershova, S. A. Shalnova, A. S. Alieva, S. S. Bazhan, O. L. Barbarash, D. Y. Bogdanov, I. A. Viktorova, Yu. I. Grinshtein, D. V. Duplyakov, O. N. Kalachikova, A. V. Kontsevaya, R. A. Libis, I. V. Medvedeva, V. A. Nevzorova, N. N. Prishchepa, O. P. Rotar, V. N. Serebryakova, I. A. Trubacheva, T. M. Chernykh, E. A. Shutemova, O. M. Drapkina, S. A. Boytsov | ||
"... and duration of lipid-lowering therapy throughout life, presence and dates of secondary causes ..." | ||
Vol 2, No 2 (2006) | METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS | Abstract similar documents |
N. V. Perova, I. N. Ozerova, V. A. Metelskaya | ||
"... Lipid metabolism issues are reviewed. Ways of cholesterol transformation are represented ..." | ||
Vol 17, No 6 (2021) | Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia | Abstract similar documents |
D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash | ||
"... , hypertension, smoking, alcohol consumption and an increase in the number of respondents taking lipid-lowering ..." | ||
Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
"... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..." | ||
Vol 8, No 6 (2012) | ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE | Abstract similar documents |
A. I. Chesnikova, V. A. Safronenko, A. V. Hripun | ||
"... — patients with low compliance. Assessment of the coronary angiography and lipid profile was performed first ..." | ||
Vol 19, No 1 (2023) | Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding | Abstract similar documents |
N. M. Vorobyeva, O. N. Tkacheva | ||
"... The review article discusses the safety issue of anticoagulant therapy in elderly patients ..." | ||
Vol 12, No 1 (2016) | Features of pharmacotherapy in the elderly patients. Introduction to the problem | Abstract similar documents |
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
"... Features of pharmacotherapy in the elderly patients are discussed. Data on the pharmacokinetics ..." | ||
Vol 13, No 1 (2017) | LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER | Abstract similar documents |
S. Yu. Martsevich, Y. V. Semenova, N. P. Kutishenko, M. L. Ginzburg, A. V. Zagrebelnyy, A. V. Fokina, E. V. Daniels | ||
"... Aim. To compare a «portrait» of a patient and hospital lethality between register LIS-1 ..." | ||
Vol 5, No 6 (2009) | RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE | Abstract similar documents |
G. I. Nechaeva, E. N. Loginova | ||
"... reception and «School of the hypertensive patient») with these of the carvedilol monotherapy in young ..." | ||
Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
"... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..." | ||
Vol 9, No 1 (2013) | ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM | Abstract similar documents |
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok | ||
"... ) on the severity of asthenic syndrome (AS) in elderly patients with arterial hypertension (HT). Material ..." | ||
Vol 14, No 6 (2018) | Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem | Abstract PDF (Eng) similar documents |
N. M. Vorobyeva, O. N. Tkacheva | ||
"... The review focuses on the use of oral anticoagulants in fragile elderly patients. The issues ..." | ||
Vol 16, No 1 (2020) | An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results | Abstract similar documents |
S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy | ||
"... .8%, diabetes mellitus – in 21.1%, atrial fibrillation – in 15.5% of patients. Lipid-lowering drugs were taken ..." | ||
Vol 9, No 2 (2013) | PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET | Abstract similar documents |
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova | ||
"... Aim. To evaluate the effect of parathyroidectomy and cinacalcet on anemia, lipid profile and blood ..." | ||
Vol 11, No 1 (2015) | CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina | ||
"... 72.9±9.8 years). Low frequency of the antihypertensive therapy (34.5%), lipid-lowering therapy (0 ..." | ||
Vol 5, No 5 (2009) | LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE | Abstract similar documents |
M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova | ||
"... and senile patients with arterial hypertension (HT) and its influence on quality of life. Material ..." | ||
Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
S. N. Bel'diev | ||
"... -lowering and anti-atherogenic effects of UDCA in patients with NAFLD. This paper presents a critical ..." | ||
Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
"... and target lipid levels achievement. Material and methods. The total of 161 type 2 diabetic patients ..." | ||
Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
S. N. Tolpygina, S. Y. Martsevich | ||
"... . 30 patients (19 men and 11 women, 64,0±1,8 y.o.) with low density lipoprotein (LDL) cholesterol ≥3 ..." | ||
Vol 15, No 5 (2019) | Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology | Abstract similar documents |
S. Yu. Nikulina, V. A. Shulman, A. A. Chernova, S. V. Prokopenko, D. A. Nikulin, I. M. Platunova, S. S. Tretyakova, V. N. Maksimov, A. A. Gurazheva | ||
"... lipid-lowering and antithrombotic therapy. ..." | ||
Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
O. M. Drapkina | ||
"... with perindopril (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid ..." | ||
Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
"... ,01) and uric acid levels were registered in group C as well as tendency to lowering of total cholesterol (TC ..." | ||
1 - 100 of 1640 Items | 1 2 3 4 5 6 7 8 9 10 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)